DaVita
DVA
#2155
Rank
NZ$14.94 B
Marketcap
NZ$208.96
Share price
0.85%
Change (1 day)
-21.05%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.12. In 2024 the company made an earnings per share (EPS) of NZ$18.99 an increase over its 2023 EPS that were of NZ$13.10.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-9.65%
2024NZ$18.9944.94%
2023NZ$13.1027.26%
2022NZ$10.30-35.56%
2021NZ$15.9844.1%
2020NZ$11.0919.7%
2019NZ$9.26540.48%
2018NZ$1.45-76.07%
2017NZ$6.04-19.31%
2016NZ$7.49242.52%
2015NZ$2.19-62.87%
2014NZ$5.8913.43%
2013NZ$5.198.45%
2012NZ$4.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
NZ$25.31 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.27-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
NZ$36.76 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.65 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA